510(k) Report

510(k) · Cleared

Cleared

Smartpill GI Monitoring System, Version 2.0

K092342510(k) TraditionalCleared Oct 30, 200987-day reviewClass II21 CFR 876.1725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

The Smartpill Corporation · NYV Gastrointestinal Motility System, Capsule

Cleared on Oct 30, 2009 after an 87-day review. The FDA summary names its predicate without a number. 3 later devices descend from it.

Decided
Oct 30, 2009
Review
87 days
Class
Class II
Product code
NYV
Recalls
None
Predicates
0

3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2025: 2 descendants cleared2026: 1 descendant cleared20052010201520202025
  1. This deviceK092342 Smartpill GI Monitoring System, Version 2.0The Smartpill Corporation · 2009
  2. Descendant · cites it directly · 1 of its ownK250940 Atmo Gas Capsule SystemAtmo Biosciences, Ltd. · 2025
  3. Descendant · 2 generations on · 0 of its ownK253569 Atmo Gas Capsule SystemAtmo Biosciences, Ltd. · 2026
  4. Descendant · cites it directly · 0 of its ownK250493 MotiliCap GI Monitoring SystemAnx Robotica Corporation · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K250940Atmo Gas Capsule SystemAtmo Biosciences, Ltd. · 2025 · cites it directly1descendant
  • K253569Atmo Gas Capsule SystemAtmo Biosciences, Ltd. · 2026 · 2 generations on0descendants
  • K250493MotiliCap GI Monitoring SystemAnx Robotica Corporation · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K092342Smartpill GI Monitoring System, Version 2.0The Smartpill Corporation2009—
+1K250940Atmo Gas Capsule SystemAtmo Biosciences, Ltd.2025—
+2K253569Atmo Gas Capsule SystemAtmo Biosciences, Ltd.2026—
+1K250493MotiliCap GI Monitoring SystemAnx Robotica Corporation2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202520
202610
FIG. 1 — Lineage of K092342, 2009–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NYV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NYV device

  1. #1 K250940 Atmo Gas Capsule Systemscore 12.6 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—SmartPill GI Monitoring System and pH.p Capsule, version 1.2
Named without a submission number
—
*—Konsyl Sitzmarks
Named without a submission number
—

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K250940Atmo Gas Capsule SystemAtmo Biosciences, Ltd.20251
K250493MotiliCap GI Monitoring SystemAnx Robotica Corporation20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K250940 (Atmo Biosciences, Ltd., 2025) has gone furthest, with 1 descendant of its own.

How does its category compare?

All NYV devices

NYV Gastrointestinal Motility System, Capsule: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · NYV

2in 2025

2009: 12025: 22026 (partial year): 1
2007high 2 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NYV

Too few NYV 510(k)s in any year since 2007 to give a median.

Recalls per year · NYV

No recall names NYV since 2007.

Adverse event reports per year · NYV

1in 2025

2008: 12009: 12010: 12011: 22012: 12015: 22016: 22017: 22019: 22020: 12021: 12022: 32023: 12024: 92025: 1
2007high 9 (2024) · low 0 (2007)2025

MAUDE reports naming product code NYV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20091—01
20100—01
20110—02
20120—01
20130—00
20140—00
20150—02
20160—02
20170—02
20180—00
20190—02
20200—01
20210—01
20220—03
20230—01
20240—09
20252—01
20261—0—

What is it indicated for?

The SmartPill GI Monitoring System measures whole gut and regional gut (stomach, small bowel, and colon) transit times. Measurements of gastrointestinal tract transit times are used for evaluating motility disorders. Gastric transit time (gastric emptying time, GET) is indicated for the evaluation of patients with suspected gastroparesis. Delayed gastric emptying is implicated in such disorders as idiopathic and diabetic gastroparesis and functional…

Read the full statement (153 words)

The SmartPill GI Monitoring System measures whole gut and regional gut (stomach, small bowel, and colon) transit times. Measurements of gastrointestinal tract transit times are used for evaluating motility disorders.

Gastric transit time (gastric emptying time, GET) is indicated for the evaluation of patients with suspected gastroparesis. Delayed gastric emptying is implicated in such disorders as idiopathic and diabetic gastroparesis and functional non-ulcer dyspepsia

Colonic transit time (CTT) is indicated for the evaluation of colonic transit in patients with chronic constipation and used to aid in differentiating slow and normal transit constipation. Combined small and large bowel transit time (SLBTT) is used as a surrogate measure of colonic transit in patients with chronic constipation when colonic transit time alone cannot be determined.

The System measures pH, pressure, and temperature throughout the GI tract. Pressure contraction data from the antrum and duodenum can be used to calculate motility-indices.

Not for use in pediatric patients.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K092342: Smartpill GI Monitoring System, Version 2.0.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K092342

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026